Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 15 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prelude Therapeutics Inc | 837,000 | reported | 04 Feb 2026 | tx 28+3,863,782−167,229 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Prelude Therapeutics Inc | 837,000 | 0.00 USD | deriv |
| 25 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 675,000 | 0.69 USD | |
| 20 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 5,416 | 0.73 USD | |
| 21 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 15,000 | 0.73 USD | |
| 17 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 9,106 | 0.75 USD | |
| 14 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 29,999 | 0.75 USD | |
| 12 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 47,500 | 0.71 USD | |
| 13 Mar 2025 | PURCHASE | Prelude Therapeutics Inc | 50,000 | 0.72 USD | |
| 04 Feb 2025 | GRANT_AWARD | Prelude Therapeutics Inc | 496,000 | 0.00 USD | deriv |
| 31 Dec 2024 | PURCHASE | Prelude Therapeutics Inc | 5,000 | 1.21 USD | |
| 30 Dec 2024 | PURCHASE | Prelude Therapeutics Inc | 10,000 | 1.20 USD | |
| 18 Dec 2024 | PURCHASE | Prelude Therapeutics Inc | 100,000 | 0.93 USD | first after silence |
| 19 Dec 2024 | PURCHASE | Prelude Therapeutics Inc | 6,888 | 0.89 USD | |
| 01 Mar 2024 | GRANT_AWARD | Prelude Therapeutics Inc | 425,000 | 0.00 USD | deriv |
| 24 May 2023 | PURCHASE | Prelude Therapeutics Inc | 1,000 | 5.01 USD | |
| 25 May 2023 | PURCHASE | Prelude Therapeutics Inc | 900 | 5.31 USD | |
| 23 May 2023 | PURCHASE | Prelude Therapeutics Inc | 11,856 | 5.63 USD | |
| 07 Feb 2023 | GRANT_AWARD | Prelude Therapeutics Inc | 330,000 | 0.00 USD | deriv |
| 20 Dec 2022 | PURCHASE | Prelude Therapeutics Inc | 19,188 | 5.13 USD | |
| 15 Feb 2022 | GRANT_AWARD | Prelude Therapeutics Inc | 327,900 | 0.00 USD | deriv |
| 13 Dec 2021 | GRANT_AWARD | Prelude Therapeutics Inc | 8,000 | 12.13 USD | |
| 20 Jul 2021 | GRANT_AWARD | Prelude Therapeutics Inc | 285,800 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | Prelude Therapeutics Inc | 101,477 | — | |
| 29 Sept 2020 | CONVERSION | Prelude Therapeutics Inc | 32,876 | — | |
| 29 Sept 2020 | CONVERSION | Prelude Therapeutics Inc | 32,876 | — |
1 purchase reported after at least 12 months of silence — most recent on 18 Dec 2024.